Atovaquone-Proguanil Hydrochloride Tablets from United States
Atovaquone-Proguanil Hydrochloride Tablets are a fixed-dose combination antimalarial medication, typically containing 250 mg of atovaquone and 100 mg of proguanil hydrochloride per tablet. They are used for the prophylaxis and treatment of malaria, particularly in regions with chloroquine-resistant strains. These tablets are classified under tariff item 3004.60.00 because they contain antimalarial active principles listed in Subheading Note 2 to Chapter 30 and are put up in measured doses for retail sale.
Duty Rate — United States → Canada
Import Tips
• Ensure the product is labelled for retail sale with dosage instructions, as required for classification under 3004.60.00
• Have a valid Drug Identification Number (DIN) from Health Canada for the product to be legally imported
• Declare the exact composition and active ingredients to the CBSA to avoid delays